Conclusion to the Symposium: The seven pillars of the cyanobacteria/BMAA hypothesis

Amyotrophic Lateral Sclerosis

Volumn 10, Issue SUPPL. 2, 2009, Pages 124-126

  Cox, Paul Alan ^a  

^a Institute for Ethnomedicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; BACTERIAL TOXIN; NEUROTOXIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; CYANOBACTERIUM; DEGENERATIVE DISEASE; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

ADRENOLEUKODYSTROPHY; ALZHEIMER DISEASE; AMINO ACIDS, DIAMINO; ANIMALS; CONGRESSES AS TOPIC; CYANOBACTERIA; ECOSYSTEM; HUMANS; MOTOR NEURONS; NEUROTOXICITY SYNDROMES; PROTEINS;

EID: 74549168896     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960903312912     Document Type: Conference Paper

References (19)

1. Cox PA, Banack SA, Murch SJ. Biomagnifi cation of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A. 2003;100:13380-3.
2. Banack SA, Johnson HE, Cheng R, Cox PA. Production of the neurotoxin BMAA by a marine cyanobacterium. Marine Drugs. 2007;5:180-96.
3. Cox PA, Banack SA, Murch SJ, Rasmussen U, Tien G, Bidigare RR, et al. Diverse taxa of cyanobacteria produce β-N-methylamino-L-alanine, a neurotoxic amino acid. Proc Natl Acad Sci U S A. 2005;102:5074-8.
4. Eriksson J, Jonasson S, Papaefthimiou D, Rasmussen U, Bergman B. Improving derivatization efficiency of BMAA utilizing AccQ-Tag® in a complex cyanobacterial matrix. Amino Acids. 2009;36:43-8.
5. Jonasson S, Eriksson J, Berntzon L, Rasmussen U, Bergman B. A novel cyano bacterial toxin (BMAA) with potential neurodegenerative effects. Plant Biotech. 2008; 51:1264-8.
6. Kubo T, Kato N, Hosoya K, Kaya K. Effective determination method for a cyanobacterial neurotoxin, β-N-methylamino-L-alanine. Toxicon. 2008;51:1264-8.
7. Rosén J, Hellenäs KE. Determination of the neurotoxin BMAA (β-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry). Analyst. 2008;133:1785-9.
8. Scott PM, Niedzwiadek B, Rawn DFK, Lau BP. Liquid chromatographic determination of the cyanobacterial toxin β-N-methylamino-L-alanine in algae food supplements, freshwater fi sh, and bottled water. J Food Protection. 2009;72:1769-73.
9. Banack SA, Murch SJ, Cox PA. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol. 2006;106:97-104.
10. Metcalf JS, Banack SA, Lindsay J, Morrison LF, Cox PA, Codd GA. Co-occurrence of β-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. Envir Micro 2008; 10:702-8.
11. Esterhuizen M, Downing TG. β-N-methylamino-L-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicology and Environmental Safety. 2008;71: 309-13.
12. Polsky FI, Nunn PB, Bell EA. Distribution of toxicity of α-amino-β-methylaminopropionic acid. Federation Proc. 1972;31:1473-5.
13. Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnifi ed cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A. 2004;101:12228-31.
14. Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW. Occurrence of β-methylamino-L-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand. 2004;110:267-9.
15. Pablo J, Banack SA, Cox PA, Johnson TE, Papapetropoulos S, Bradley WG, et al. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand. 2009; 120: 216-225.
16. Rodgers KJ, Shiozawa N. Misincorporation of amino acid analogues into proteins by biosynthesis. Int J Biochem Cell Bio. 2008;40:1452-66.
17. Allende CC, Allende JE. Purifi cation and substrate specificity of arginyl-ribonucelic acid synthetase from rat liver. J Biol Chem. 1964;239:1102-6.
18. Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CHM, Cook SA et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature. 2006; 443:50-55.
19. Rao SD, Banack SA, Cox PA, Weiss JH. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp Neurol. 2006;201:244-52.